FDA Approves Omcazio (cabozantinib) Capsule Formulation for Administration Without Regard to Food
RegulatoryapprovedOmcazioPositive
AI Analysis
Summary
The FDA has granted final approval for Omcazio (cabozantinib) capsule formulation that can be administered without regard to food, announced by Handa Pharmaceuticals. This regulatory approval represents a significant advancement in cabozantinib's patient administration convenience.
Outcome Details
FDA granted final approval for cabozantinib capsule formulation for administration without regard to food
Importance:8/10
Sentiment:
0.90
FDA approvalformulationcabozantinibregulatory milestone
Related Companies
Read the original article
Published by Drugs.com New Drug Approvals on September 11, 2026 11:09 PM